Clinical Trial Search

Primary: Percentage of Participants With Treatment-emergent Drug-related Adverse Events (AEs) — 4.5; 0; 22.2; 0 percentage of participants

Primary: Mammographic Breast Density Using Cumulus Software — -6.30; -5.77; -2.81; -5.43 Percent Change in Breast Density

Primary: Number of Eyelids With Post-operative Trichiasis Within 12 Months — 94; 120 Eyelids — p=0.07

Primary: Area Under the Concentration-time Curve of BI 1323495 in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point — NA; NA nanomol (nmol) * hours (h) /…

Primary: SRD and MD Part: Number of Participants With Drug-related Adverse Events (AEs) — 1; 2; 1; 0 Participants

Primary: Investigator's Rating of Glabellar Line Severity at Maximum Frown by Live Assessment. — 18; 18; 22; 19 Participants

Primary: Change in Glycemic Control — 8.99; 8.20 % of glycated hemoglobin

Primary: Post-operative Pain Levels — 5.1; 5.1; 6.1 score on a scale

Primary: Evidence-based Cessation Treatment Utilization — 44; 10; 51; 11 Participants

Primary: Ischemic Risk Post-PCI in High Bleed Risk Patients With Genotype-guided Single Antiplatelet Therapy — 0; 1 Participants

Primary: Number of Participants Who While Using the Final Version of Remote Assist, Are Able to Complete the Primary Tasks (Score of 5 on the Usability Rating Scale) — 13…

Primary: Percentage of Participants With Drug-related Adverse Events (AEs) — 0; 12.5; 25.0; 37.5 Percentage of participants

Primary: Hospital Length of Stay — 9; 6 days

Primary: Percentage of Participants With Negative Ice Cube Provocation Test at Week 24 — 37.5; 40.5 percentage of participants — p=0.9492

Primary: Delirium — 3; 3; 1; 2 Participants — p=0.653